SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-127783
Filing Date
2021-04-23
Accepted
2021-04-23 07:00:51
Documents
6
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d48108ddef14a.htm DEF 14A 357107
2 GRAPHIC g48108g20h05.jpg GRAPHIC 4830
3 GRAPHIC g48108g50c16.jpg GRAPHIC 51277
4 GRAPHIC g48108g56q65.jpg GRAPHIC 31419
5 GRAPHIC g48108g62j47.jpg GRAPHIC 4869
6 GRAPHIC g48108sp1a.jpg GRAPHIC 4598
  Complete submission text file 0001193125-21-127783.txt   492384
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38529 | Film No.: 21846661
SIC: 2834 Pharmaceutical Preparations